Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Profound decrease of in vivo formation of thromboxane during oestrogen therapy

P Henriksson1, R Stege, K Gréen

  • 1Department of Medicine, Södertälje Hospital, Sweden.

European Journal of Clinical Investigation
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.

Transplant infectious disease : an official journal of the Transplantation Society·2005
Same author

Health literacy and patient knowledge in a Southern US HIV clinic.

International journal of STD & AIDS·2004
Same author

Effects of instructions on physical capacities outcome in a workers' compensation setting.

Pain medicine (Malden, Mass.)·2004
Same author

Improved glucose homeostasis in mice overexpressing human UCP3: a role for AMP-kinase?

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2004
Same author

Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience.

Scandinavian journal of infectious diseases·2003
Same author

Changes in EBV gene load in renal transplant recipients.

Transplantation proceedings·2003

Parenteral estrogen therapy significantly reduces in vivo thromboxane formation by about 40% in men with prostate cancer. This estrogen effect on thromboxane and prostacyclin balance may benefit cardiovascular health.

Area of Science:

  • Endocrinology
  • Cardiovascular Physiology
  • Metabolomics

Background:

  • Estrogen's influence on platelet activity and eicosanoids (thromboxane, prostacyclin) is debated.
  • Previous studies relied on ex vivo methods with potential artifacts.
  • In vivo assessment of eicosanoid formation is crucial for accurate understanding.

Purpose of the Study:

  • To investigate the in vivo effects of estrogen therapy on thromboxane and prostacyclin formation in men.
  • To compare estrogen therapy with surgical castration in modulating these vasoactive eicosanoids.

Main Methods:

  • Analysis of urinary metabolites 2,3-dinor-thromboxane B2 and 2,3-dinor-6-keto-PGF1 alpha using gas chromatography/mass spectrometry.
  • Study included 10 male prostate cancer patients undergoing parenteral estrogen therapy or orchidectomy.

Related Experiment Videos

  • Utilized tetradeuterated internal standards for precise quantification.

    • Main Results:

    • Parenteral estrogen therapy decreased in vivo thromboxane formation by approximately 40%.
    • Surgical castration led to a doubling of thromboxane formation.
    • The prostacyclin to thromboxane ratio increased by approximately 50% during estrogen therapy.

    Conclusions:

    • Estrogen significantly reduces in vivo thromboxane formation and increases the prostacyclin/thromboxane ratio.
    • These findings suggest potential cardiovascular benefits of estrogen therapy.
    • Increased thromboxane formation post-castration highlights the influence of androgens and sex hormones on this system.